NCT01437007View on ClinicalTrials.gov

TKM 080301 for Primary or Secondary Liver Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

August 26, 2011

Primary Completion Date

June 21, 2012

Study Completion Date

June 21, 2012

Conditions
Colorectal Cancer With Hepatic MetastasesPancreas Cancer With Hepatic MetastaseGastric Cancer With Hepatic MetastaseBreast Cancer With Hepatic MetastaseOvarian Cancer With Hepatic Metastase
Interventions
DRUG

TKM-080301

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01437007 - TKM 080301 for Primary or Secondary Liver Cancer | Biotech Hunter | Biotech Hunter